ISSN 2326-7267
International Journal of Pharmacy and Pharmacology ISSN 2326-7267 Vol. 14 (3), pp. 001-008, March, 2025. Available online at www.internationalscholarsjournals.org © International Scholars Journals
Full Length Research Paper
Transdermal Delivery of Ligustrazine Phosphate Using Microemulsions: A Formulation Investigation
Ying Cui1,2, Lingzhi Li1,2, Jun Gu1, Ting Zhang3* and Li Zhang1
1Department of Medicine Chemistry, Logistics University of Chinese People’s Armed Police Forces, Tianjin 300162,
P. R. China.
2Tianjin Key Laboratory of Occupational and Environmental Hazards Biomarkers, Tianjin 300162, P. R. China.
3Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, P. R. China.
Accepted 10 January, 2025
Ligustrazine phosphate is commonly used as an efficient drug to treat a variety of cardiovascular disorders with frequent administration for a short biological half-life. The purpose of the present study was to investigate a microemulsion system for transdermal delivery of ligustrazine phosphate for the convenient, efficient and safe administration. The existence regions of microemulsions containing isopropyl myristate, labrasol, plurol oleique® and water were investigated in pseudo-ternary phase diagrams, according to which microemulsion vehicles were prepared to observe average diameter, pH value, stability and evaluate respective effect of each component on percutaneous delivery in vitro. The prepared microemulsions had average diameters ranging from 32.1 to 108.7 nm, mild pH values and suitable stability. The optimized microemulsion with permeation flux of 41.01 g/cm2/h across rat skin in vitro, showed no obvious irritation on back skin of rabbits. The results indicated that the studied microemulsion system might be a promising vehicle for transdermal delivery of ligustrazine phosphate.
Key words: Microemulsion, transdermal delivery, ligustrazine phosphate.